Graphene Oxide Based Theranostic Platform forT1-Weighted Magnetic Resonance Imaging and Drug Delivery
Source abstract
Abstract
Magnetic resonance imaging (MRI) is a powerful and widely used clinical technique in cancer diagnosis. MRI contrast agents (CAs) are often used to improve the quality of MRI-based diagnosis. In this work, we developed a positive T1 MRI CA based on graphene oxide (GO)-gadolinium (Gd) complexes. In our strategy, diethylenetriaminepentaacetic acid (DTPA) is chemically conjugated to GO, followed by Gd(III) complexation, to form a T1 MRI CA (GO-DTPA-Gd). We have demonstrated that the GO-DTPA-Gd system significantly improves MRI T1 relaxivity and leads to a better cellular MRI contrast effect than Magnevist, a commercially used CA. Next, an anticancer drug, doxorubicin (DOX), was loaded on the surface of GO sheets via physisorption. Thus-prepared GO-DTPA-Gd/DOX shows significant cytotoxicity to the cancer cells (HepG2). This work provides a novel strategy to build a GO-based theranostic nanoplatform with T1-weighted MRI, fluorescence imaging, and drug delivery functionalities.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Graphene research and applications · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Suzhou Key Laboratory of Nanobiomedicine, Division of Nanobiomedicine, Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, 398 Ruoshui Road, Suzhou 215123, China
University of Chinese Academy of Sciences, 19 (A) Yuquan Road, Beijing 100049, China
Division of Nanobionics, Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, 398 Ruoshui Road, Suzhou 215123, China
Imaging Centre, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
References (43)
Show source-provided references
1. Chaughule R. S. · Proc. Natl. Acad. Sci., India, Sect. A · 2012 · 82 · 25710.1007/s40010-012-0038-4 ↗
2. Zhou Z. X. · Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. · 2013 · 5 · 110.1002/wnan.1198 ↗
3. Caravan P. · Chem. Rev. · 1999 · 99 · 229310.1021/cr980440x ↗
4. Laurent S. · Chem. Rev. · 2008 · 108 · 206410.1021/cr068445e ↗
5. Letourneau M. · J. Phys. Chem. B · 2012 · 116 · 1322810.1021/jp3032918 ↗
6. Ma X. H. · J. Mater. Chem. B · 2013 · 1 · 341910.1039/c3tb20648c ↗
7. Cheng Y. Y. · Chem. Soc. Rev. · 2011 · 40 · 267310.1039/c0cs00097c ↗
8. Botta M. · Eur. J. Inorg. Chem. · 2012 · 194510.1002/ejic.201101305 ↗
9. Mikawa M. · Bioconjugate Chem. · 2001 · 12 · 51010.1021/bc000136m ↗
10. Bolskar R. D. · J. Am. Chem. Soc. · 2003 · 125 · 547110.1021/ja0340984 ↗
11. Zhen M. M. · ACS Appl. Mater. Interfaces · 2012 · 4 · 372410.1021/am300817z ↗
12. Sitharaman B. · Chem. Commun. · 2005 · 391510.1039/b504435a ↗
13. Hartman K. B. · Nano Lett. · 2008 · 8 · 41510.1021/nl0720408 ↗
14. Gianolio E. · Eur. J. Inorg. Chem. · 2012 · 2012 · 193410.1002/ejic.201101399 ↗
15. Geim A. K. · Nat. Mater. · 2007 · 6 · 18310.1038/nmat1849 ↗
16. Neto A. C. · Rev. Mod. Phys. · 2009 · 81 · 10910.1103/RevModPhys.81.109 ↗
17. Schwierz F. · Nat. Nanotechnol. · 2010 · 5 · 48710.1038/nnano.2010.89 ↗
18. Chen D. · Chem. Soc. Rev. · 2010 · 39 · 315710.1039/b923596e ↗
19. Sun Y. Q. · Energy Environ. Sci. · 2011 · 4 · 111310.1039/c0ee00683a ↗
20. Sun X. M. · Nano Res. · 2008 · 1 · 20310.1007/s12274-008-8021-8 ↗
21. Pan Y. Z. · Expert Opin. Drug Delivery · 2012 · 9 · 136510.1517/17425247.2012.729575 ↗
22. Shen H. · Theranostics · 2012 · 2 · 28310.7150/thno.3642 ↗
23. Feng L. Z. · Nanomedicine · 2011 · 6 · 31710.2217/nnm.10.158 ↗
24. Shen A. J. · J. Biomed. Mater. Res. A · 2012 · 100 · 249910.1002/jbm.a.34148 ↗
25. Liu Z. · J. Am. Chem. Soc. · 2008 · 130 · 1087610.1021/ja803688x ↗
26. Zhang L. M. · Small · 2011 · 7 · 46010.1002/smll.201001522 ↗
27. Singh S. K. · ACS Nano · 2011 · 5 · 498710.1021/nn201092p ↗
28. Yang K. · ACS Nano · 2010 · 5 · 51610.1021/nn1024303 ↗
29. Singh S. K. · ACS Nano · 2012 · 6 · 273110.1021/nn300172t ↗
30. Janib S. M. · Drug Delivery Rev. · 2010 · 62 · 105210.1016/j.addr.2010.08.004 ↗
31. Kelkar S. S. · Bioconjugate Chem. · 2011 · 22 · 187910.1021/bc200151q ↗
32. Choi K. Y. · Nanoscale · 2012 · 4 · 33010.1039/C1NR11277E ↗
33. Zhang L. M. · Small · 2010 · 6 · 53710.1002/smll.200901680 ↗
34. Chen Z. J. · J. Drug Targeting · 2011 · 19 · 65710.3109/1061186X.2010.531727 ↗
35. Liu Y. J. · Biomaterials · 2012 · 33 · 536310.1016/j.biomaterials.2012.03.084 ↗
36. Hong H. · Biomaterials · 2012 · 33 · 414710.1016/j.biomaterials.2012.02.031 ↗
37. Sherlock S. P. · ACS Nano · 2011 · 5 · 150510.1021/nn103415x ↗
38. Wu L. · Adv. Mater. · 2012 · 24 · 244710.1002/adma.201200412 ↗
39. Zhang L. M. · J. Mater. Chem. B · 2013 · 1 · 74910.1039/C2TB00096B ↗
40. Shen H. · ACS Appl. Mater. Interfaces · 2012 · 4 · 631710.1021/am3019367 ↗
41. Yang X. M. · ACS Appl. Mater. Interfaces · 2010 · 2 · 170710.1021/am100222m ↗
42. Huang J. · Nanoscale · 2013 · 5 · 1059110.1039/c3nr03264g ↗
43. Huang J. · Small · 2012 · 8 · 257710.1002/smll.201102743 ↗